Drug intelligence / Profile preview

Xiaoke Jiangtang Capsule

Development stage: Unknown
Lead developer: Shanxi Buchang Pharmaceutical
Administration: Oral

Overview

Xiaoke Jiangtang Capsule is a Traditional Chinese Medicine (TCM) formulation developed and manufactured by Shanxi Buchang Pharmaceutical for the treatment of diabetes mellitus. As a TCM product, it is specifically indicated for the management of "Xiaoke" (wasting-thirst syndrome), a traditional diagnostic category that corresponds to diabetes in Western medicine. The capsule is composed of multiple botanical extracts that work synergistically to lower blood glucose levels, improve insulin sensitivity, and alleviate common diabetic symptoms such as excessive thirst and frequent urination. It is currently approved and marketed in China.

Brand names: Xiaoke Jiangtang Capsule
Other names: Xiaoke Jiangtang Capsule消渴降糖胶囊

Beyond the preview

Go deeper on Xiaoke Jiangtang Capsule.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Xiaoke Jiangtang Capsule.

Explore the full profile